Recent Comments
- E L on Exclusive: The gender reassignment butchers have taken over my NYU surgery
- LoveKatz67 on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
- Truth Clearware on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
- EricUniqueUsername on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
- ThunderbirdRocket on Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market
Most Viewed Posts
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (14,181)
- New treatment paradigm for C. Diff colitis (14,080)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (13,593)
- How the FDA regulates compounding pharmacies (13,245)
- The Healthcare Channel hits 10 (12,176)
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (10,786)
- The new CDC guidelines for prescribing opioid pain pills (8,014)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (7,162)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (6,997)
- The MusiCorps benefit concert 2015 (6,056)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: Henry Ford
Catheter approaches for mitral replacement
March 23, 2014- interviewed by Steven E. Greer, MD With catheter based methods for replacing the aorta valve not being adopted as expected, the
Posted in - Medical Devices, Cardiac surgery, Cardiology, Henry Ford
Leave a comment
Insurance companies are not paying for Repatha and Praluent
Update November 2, 2018- Amgen slashed the annual cost of this drug to $6,000.
Review of the TCT 2015 data
October 19, 2015
Posted in - Medical Devices, Cardiac surgery, Cardiology, Henry Ford
Leave a comment
Occluding the left atrial appendage to prevent stroke in A-fib
May 17, 2014- Thromboembolic stroke caused by atrial fibrillation is the primary reason patients are placed
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford
Leave a comment
TAVI: Comparing CoreValve to Sapien
November 8, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD of Henry Ford discusses the recent pivotal data for the Medtronic CoreValve device,
Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA, Henry Ford
Leave a comment
Bioabsorbable stents
May 14, 2013- William O’Neill, MD of Henry Ford discusses bioabsorbable coronary stents, and the U.S. Abbott trials.
Posted in Cardiac surgery, Cardiology, Henry Ford
Leave a comment
Renal denervation devices to treat hypertension
William O’Neill, MD of Henry Ford Hospital discusses renal denervation devices used to treat refractory hypertension. He is involved with the Medtronic device trials.
Posted in - Medical Devices, Cardiology, FDA, Henry Ford
Leave a comment
TAVR Finances: William O’Neill, MD
Interviewed by Steven E. Greer, MD The clinical adoption of Transcatheter Aortic Valve Replacement (TAVR) has been slower than
Posted in Cardiac surgery, Cardiology, Henry Ford
Leave a comment
TAVR collaboration
April 12, 2013- Interviewed by Steven E. Greer, MD William O’Neill, MD, Director of the Structural Heart Disease Center at Henry Ford Hospital,
Posted in - Medical Devices, Henry Ford
Leave a comment